Stryker
Stryker is a medical technologies company, that operates through three business segments: orthopedics, medical and surgical, and neurotechnology and spine. Orthopedics segment consists primarily of implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg products include surgical equipment and navigation, endoscopic and communications systems, patient handling and emergency medical equipment, and reprocessed and remanufactured medical devices. Neurotechnology and spine portfolio includes both neurosurgical and neurovascular devices used for minimally invasive endovascular techniques. It also offers products for traditional brain and open skull base surgical procedures, orthobiologic and biosurgery and vertebral augmentation products. Stryker also develops, manufactures and markets spinal implant products including cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stryker was founded in 1941 and is headquartered in Kalamazoo, US
Report incorrect company information
Key People/Management at Stryker
Yin Becker
Vice President, Communications and Public Affairs
Dean Bergy
Vice President, Corporate Secretary
William Berry
Vice President, Corporate Controller
Jeanne Blondia
Vice President, Finance and Treasurer
Glenn Boehnlein
Vice President, Chief Financial Officer
Lonny Carpenter
Group President and Advisor to the CEO
Report incorrect company information
Stryker Office Locations
Stryker has offices in Arlington County, Gurugram, Chandigarh, Chennai and in 306 other locations
Kalamazoo, US (HQ)
2825 Airview Boulevard
Davie, US
555 Davie Road
Parkway Portage, US
1901 Romence Road
Portage, US
750 Trade Centre Way, Suite 200
Buenos Aires, AR
Av. Las Heras 1947 4 Piso. Capital Federal
St Leonards, AU
8 Herbert St
Report incorrect company information
Stryker Financials and Metrics
Stryker Financials
Stryker's revenue was reported to be $11.33 b in FY, 2016 which is a 13.9% increase from the previous period.
| USD | |
|---|---|
Revenue (Q1, 2018) | 3.2 b |
Gross profit (Q1, 2018) | 2.1 b |
Gross profit margin (Q1, 2018), % | 65.9% |
Net income (Q1, 2018) | 443 m |
EBIT (Q1, 2018) | 591 m |
Market capitalization (23-May-2018) | 65.6 b |
Closing share price (23-May-2018) | 175.4 |
Cash (31-Mar-2018) | 2.2 b |
Stryker's current market capitalization is $65.6 b.
Annual
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 9 b | 9.7 b | 9.9 b | 11.3 b |
Revenue growth, % | 7% | 3% | 14% | |
Cost of goods sold | 3 b | 3.3 b | 3.3 b | 3.8 b |
Gross profit | 6 b | 6.4 b | 6.6 b | 7.5 b |
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.2 b | 2.3 b | 2.4 b | 2.4 b | 2.4 b | 2.4 b | 2.4 b | 2.5 b | 2.8 b | 2.8 b | 3 b | 3 b | 3 b | 3.2 b |
Cost of goods sold | 682 m | 769 m | 808 m | 822 m | 826 m | 827 m | 796 m | 801 m | 998 m | 960 m | 993 m | 1 b | 1 b | 1.1 b |
Gross profit | 1.5 b | 1.5 b | 1.6 b | 1.6 b | 1.6 b | 1.6 b | 1.6 b | 1.7 b | 1.8 b | 1.9 b | 2 b | 2 b | 2 b | 2.1 b |
Gross profit Margin, % | 68% | 67% | 66% | 66% | 65% | 66% | 67% | 68% | 65% | 66% | 66% | 66% | 66% | 66% |
Annual
| usd | Y, 2011 | Y, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|
Cash | 905 m | 1.4 b | 1.3 b | 1.8 b | 3.4 b | 3.3 b |
Inventories | 535 m | 524 m | 564 m | 480 m | ||
Current Assets | 8.3 b | 9.7 b | 7.9 b | 7.9 b | ||
Goodwill | 3.8 b | 4.2 b | 4.1 b | 6.4 b |
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 1.1 b | 1.4 b | 1.3 b | 1.4 b | 1.7 b | 3.6 b | 3.2 b | 7 b | 3.5 b | 3 b | 3.2 b | 3.6 b | 2.6 b | 2.2 b |
Accounts Receivable | 72 m | |||||||||||||
Inventories | 210 m | 231 m | 254 m | 257 m | 260 m | 270 m | 296 m | 325 m | 363 m | 396 m | 476 m | 495 m | 602 m | 554 m |
Current Assets | 9.2 b | 8.4 b | 9.4 b | 9.3 b | 8.7 b | 8.9 b | 8 b | 11.3 b | 7.8 b | 7.4 b | 7.9 b | 8.5 b | 7.7 b | 7.9 b |
Annual
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 1 b | 515 m | 1.4 b | 1.6 b |
Inventories | (77 m) | (173 m) | (115 m) | (299 m) |
Accounts Payable | 1 m | 13 m | 35 m | (16 m) |
Cash From Operating Activities | 1.9 b | 1.8 b | 899 m | 1.8 b |
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 103 m | 70 m | 128 m | 57 m | 224 m | 616 m | 917 m | 402 m | 782 m | 1.1 b | 444 m | 835 m | 434 m | 443 m |
Depreciation and Amortization | 42 m | 46 m | 94 m | 97 m | 94 m | 188 m | 289 m | 102 m | 247 m | 395 m | 150 m | 310 m | 473 m | 176 m |
Inventories | (43 m) | (61 m) | (59 m) | (97 m) | (42 m) | (67 m) | (124 m) | (109 m) | (225 m) | (307 m) | (114 m) | (192 m) | 602 m | (144 m) |
Accounts Payable | (1 m) | 30 m | (19 m) | 4 m | 8 m | 17 m | 15 m | 17 m | (5 m) | (11 m) | 23 m | (12 m) | 458 m | 33 m |
| USD | Y, 2018 |
|---|---|
Financial Leverage | 2.4 x |
Stryker Operating Metrics
| FY, 2014 | FY, 2015 | FY, 2016 | |
|---|---|---|---|
Patents (US) | 1.90 k | 1.88 k | 2.18 k |
Patents (foreign) | 3.40 k | 3.01 k | 3.45 k |
Report incorrect company information
Stryker News and Updates
May 25, 2018
Compression Bone Screws Market Attractiveness, Competitive Landscape and Forecasts to 2023
The study of the Compression Bone Screws market by HTF MI provides the market size information and market trends along with factors and parameters impacting it in both short- and long-term. Posted via Industry Today. Follow us on Twitter @IndustryToday
May 24, 2018
Cystoscopes Market Research Size, Shares, Strategies, Trend, Growth And Forecasts Worldwide 2026
The global cystoscopes market accounted to a market value of US$ 334.9 Mn in 2017 and expected to grow with a CAGR of 6.9% during the forecast period from 2018 to 2026 Posted via Industry Today. Follow us on Twitter @IndustryToday
May 23, 2018
Ortho And Osteobiologics Market to Witness a Pronounce Growth During 2016-2024
Ortho and Osteobiologics Market: Global Industry Analysis and Forecast 2016 - 2024 Posted via Industry Today. Follow us on Twitter @IndustryToday
May 22, 2018
Research Report and Overview on Tenodesis Devices Market, 2017-2025
Persistence Market Research has announced the addition of the “Tenodesis Devices Market: Global Industry Analysis and Opportunity Assessment, 2017-2025"report to their offering Posted via Industry Today. Follow us on Twitter @IndustryToday
May 21, 2018
Spinal Stenosis Implant Market Growth to be Propelled by Increasing Demand 2025
Increasing prevalence of spinal stenosis is one of the major factor driving the growth of spinal stenosis implant market. Posted via Industry Today. Follow us on Twitter @IndustryToday
May 17, 2018
Killed Negatives: Why did the US government ruin these photos?
Somewhere in a darkroom in Washington DC, between the years of 1935 and 1944, Roy Stryker of the Farm Security Administration sat at a desk and punched neat round holes into thousands upon thousands of negatives. As head of the agency’s Information Division, he had commissioned one of the largest ev…
Report incorrect company information